City page
Kuopio biotech and pharma directory
This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.
Where does this city read strongest?
Therapeutics (3), CDMO (2), and CRO (2). Most visible records: Adamant Health Oy, Aranda Pharma Ltd., and Aurealis Therapeutics.
Which standards and public evidence are already visible?
GMP (3), GLP (1), ISO-13485 (1), and FDA-Inspected (2). Latest review: 24 April 2026. Review cycle: April 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Kuopio.
By category
Kuopio by category
Jump into a category page filtered to this country only.
Full list
Kuopio biotech and pharma directory
9 city records currently match the active filter.
Current review cycle
Adamant Health Oy
KuopioFinlandDiagnostics
Kuopio digital-health medtech startup building wearable sensor and surface EMG analytics for Parkinson's disease and movement-disorder symptom quantification, CE-marked medical device and a Gerresheimer partnership.
- Lead
- Paulus CarpelanChief Executive Officer and Co-Founder
- Scale
- Medical-device and digital health delivery
Current review cycle
Aranda Pharma Ltd.
KuopioFinlandTherapeutics
Kuopio preclinical-stage pharma SME developing non-steroidal small-molecule androgen-receptor inhibitors for topical hair loss and acne treatments, with GLP safety studies via partners.
- Lead
- Mika KayhkoChief Executive Officer
- Scale
- Preclinical small-molecule development
Current review cycle
Aurealis Therapeutics
KuopioFinlandTherapeutics
Kuopio clinical-stage live-biotherapeutic company engineering lactic-acid bacteria to secrete therapeutic proteins, with lead candidate AUP-16 in Phase 1 for diabetic foot ulcers; group headquarters in Schlieren, Switzerland.
- Lead
- Juha YrjanheikkiChief Executive Officer and Co-Founder
- Scale
- Clinical-stage live-biotherapeutic development
Current review cycle
Bone Index Finland Ltd.
KuopioFinlandDiagnostics
Kuopio medical-device company developing the Bindex point-of-care pulse-echo ultrasound for osteoporosis diagnosis, FDA 510(k)-cleared and CE-marked.
- Lead
- Janne KarjalainenChief Executive Officer
- Scale
- Medical-device manufacturing
Current review cycle
Kuopio Center for Gene and Cell Therapy
KuopioFinlandCDMO
Kuopio ATMP CDMO providing Fimea-authorized GMP viral-vector manufacturing (AAV, adenovirus, lentivirus) for gene and cell therapy programs, owned by Ferring Ventures since 2020.
- Lead
- Tuija KekarainenScientific Director and Cell Therapy Unit Director
- Scale
- GMP viral-vector manufacturing
Current review cycle
Oy Medfiles Ltd.
KuopioFinlandCRO
Kuopio full-service CRO owned by WDB Holdings (Japan), covering Phase I-IV clinical trials, bioanalytics, regulatory affairs, pharmacovigilance, and medical device and food studies across the EU and Japan.
- Lead
- Tuija KeinonenChief Executive Officer
- Scale
- Full-service CRO operations
Current review cycle
Rokote Laboratories Finland
KuopioFinlandTherapeutics
Finnish clinical-stage vaccine biotech developing a nasal adenoviral-vector COVID-19 vaccine and broader respiratory vaccine programs, with first-in-human trials underway at Kuopio University Hospital and partner GMP supply.
- Lead
- Erkko YlosmakiChief Executive Officer
- Scale
- Clinical-stage vaccine development
Current review cycle
Charles River Laboratories Finland
KuopioFinlandCRO
Kuopio neuroscience-focused discovery center within Charles River, offering in vitro and in vivo pharmacology, imaging, behavioral testing, and biomarker analysis from Finland.
- Lead
- James C. FosterChairman, President and CEO
- Scale
- Discovery-services platform
Current review cycle
FinVector
KuopioFinlandCDMO
Kuopio gene-therapy CDMO and viral-products manufacturer operating cGMP production, drug-substance and drug-product suites, and a growing pharma campus in Savilahti.
- Lead
- Matthias KriegerManaging Director
- Scale
- Clinical-to-commercial gene-therapy manufacturing
Related briefs
Briefs that mention Kuopio
Viral Vector CDMO Europe 2026: AAV, Adenovirus, Lentivirus
Where to manufacture viral vectors in Europe in 2026 — FinVector, Kuopio Center for Gene and Cell Therapy, 3PBIOVIAN, Fuse Vectors, IDT Biologika — and how the European viral vector CDMO layer is structured.
Open briefNordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefCell & Gene Therapy Europe 2026: CAR-T, Stem Cell, ATMP, Regenerative
A practical map of the European cell and gene therapy landscape in 2026 — CAR-T and TCR-T therapeutics, stem-cell and regenerative ATMPs, tissue engineering, plus the viral-vector CDMO and tools supply chain — across 26 operators in the directory.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.